Skip to main content

Antepartum DVT clinical trials at UC Health

1 research study open to eligible people

Showing trials for
  • Heparin Prophylaxis Dosing for Antepartum Hospitalizations (HEPDOSE)

    open to eligible females ages 18-50

    This study is a randomized control trial to compare gestational age-based dosing with standard dosing of unfractionated heparin for thromboprophylaxis of hospitalized antepartum patients. The investigators aim to determine the effect of dosing on receipt of neuraxial anesthesia and pregnancy outcomes and evaluate the pharmacokinetics and pharmacodynamics of unfractionated heparin in pregnancy.

    at UCLA

Last updated: